The GP4-Tm was chosen as a model antigen as it contains a B-cell epitope that consistently induces neutralizing antibodies upon infection, and neutralizing antibodies are considered a good correlate for protection against PRRSV [14], [40]. This evidence concerns the gene CD36 and infection.